Abstract
A novel, microwave-assisted method producing anilines and phenols from activated aryl halides is reported. This high-yielding method reduces current reaction requirements and removes organic solvents and catalysts making a more efficient and eco-friendly alternative for the synthesis of important pharmaceutical building blocks.

Keywords: Amination, hydroxylation, reduction, benzenediamine, aminophenol
Introduction
Aromatic amines and phenols are found abundantly in medicinally relevant compounds. The ease at which they form bonds has made them heavily utilized for drug synthesis and, due to their high value, efficient methods for their production have been long sought after. Traditionally, amination and hydroxylation reactions involved the use of liquid ammonia or concentrated strong bases, high pressure, high temperature, and long reaction times (1) and, in the case of phenols, sometimes in two steps (2).
There have been significant efforts to improve the safety and efficiency of traditional methods for aminations and hydroxylations. One common method was employing metal catalysts, typically palladium (3–10), copper (11–19), nickel (20), or iron (21). While these made improvements by decreasing temperature and pressure, the reactions still require organic solvents and lengthy reaction times. Although metal-catalysis permits the facile synthesis of anilines and phenols, environmental impact warrants identification of greener conditions.
Work has been completed to decrease the environ-mental burden of aminations and hydroxylations. Multiple groups have reported methods using green ligands (22–24) or green solvents like ammonia (24) or water (13,21, 25–27). These works represent a significant step in making amination and hydroxylation more ecofriendly but still requires the use of environmentally toxic copper. Further, many reaction durations are on the scale of 12 or more hours, significantly increasing iteration time for the synthesis of chemical libraries used for drug discovery programs.
The rise of microwave irradiation has allowed for many reactions to be revisited and further optimized due to its ability to steadily control high temperatures and pressures (28). However, it has rarely been utilized to aminate and hydroxylate activated aryl halides. Recently, Yu et al. (29) reported a microwave-assisted method for the hydroxylation of aryl halides, but similar to previous methods, still required metal catalyst, ligand, and organic solvents.
Herein, we report a short duration, high yielding, nucleophilic aromatic substitution reaction that removes the need for catalysts and organic solvents (Scheme 1). We have achieved this through activated aryl halides in an aqueous ammonium hydroxide or lithium hydroxide solution under microwave irradiation. Additionally, we have developed a one-pot amination and reduction protocol to rapidly access benzenediamine analogs. This method increases the scope and efficiency of accessing important pharmaceutical building blocks.
Scheme 1.

Synthetic routes to pharmaceutically relevant intermediates using the reported method.
This aromatic substitution technique improves on current protocols and has the potential for industrial scale-up. Briefly, it requires decreased reaction times with minimal purification efforts.To lessen environmental impact, organic solvents and metal catalysts have been substituted with simple aqueous solutions. From an industrial standpoint, the use of aqueous solutions is much safer, which avoids toxic, volatile, and/or combustible organic solvents. Also, reaction conversions are typically 100% making purification requirements nominal to help reduce cost and increase industrial adaptation.
Results and discussion
Optimization studies for amination were carried out using 100 mg of 1a in 2 mL of 28–30% ammonium hydroxide solution to determine the temperature that yielded complete conversion with the shortest reaction duration (Table 1). It was observed that heating at 110°C for 10 min was sufficient for complete conversion (Table 1, entry 3), but at 130°C, the reaction duration was decreased to as little as 5 min (Table 1, entry 5).
Table 1.
Optimization studies of 1a.a

| Entry | Temp (°C) | Time (min.) | Conv. (%)b |
|---|---|---|---|
| 1 | 70 | 10 | 11 |
| 2 | 90 | 10 | 50 |
| 3 | 110 | 10 | 100 |
| 4 | 130 | 10 | 100 |
| 5 | 130 | 5 | 100 |
Conditions: 100 mg 1a added to 2 mL solvent. Heated in a sealed vessel in microwave.
Determined by 1HNMR.
Following optimization, we explored the scope of the reaction. We altered the position of the fluorine group to confirm its reactivity to the para position (Table 2, entry 2) and its lack of reactivity to the meta position (Table 2, entry 3). Additional halogen substituents were added to test for any steric interference (Table 2, entries 4–6), and full conversion was still observed. The selectivity of fluorine in the reaction over other halogens was tested by placing bromine para and fluorine ortho to the nitro group (Table 2, entry 7). The fluorine underwent full conversion and no additional side products were observed. Furthermore, 100% conversion was still observed with the addition of electron donating methyl (Table 2, entry 17) and methoxy (Table 2, entry 18) groups ortho to fluorine.
Table 2.
Synthesis of amines from aryl halidesa.
| Entry | Subst. | Prod. | Conv.b (%) | Yield (%) | Entry | Subst. | Prod. | Conv.b (%) | Yield (%) |
|---|---|---|---|---|---|---|---|---|---|
| 1 |
|
|
100 | 93 | 10 |
|
|
100 | 99 |
| 2 |
|
|
100 | 94 | 11 |
|
|
100 | 96 |
| N/A | |||||||||
| 3 |
|
|
0 | 12c, d |
|
|
80 | 78 | |
| 4 |
|
|
100 | 98 | 13 |
|
|
0 | N/A |
| 5 |
|
|
100 | 99 | 14 |
|
|
0 | N/A |
| 6 |
|
|
100 | 86 | 15c, d |
|
|
100 | 90 |
| 7 |
|
|
100 | 97 | 16c, d |
|
|
20 | 15 |
| 8 |
|
|
100 | 96 | 17 |
|
|
100 | 99 |
| 9 |
|
|
100 | 84 | 18 |
|
|
100 | 84 |
Conditions: Unless otherwise stated, 100 mg starting material added to 2 mL of 30% NH4OH. Heated in microwave at 130°C for 10 min.
Determined by 1HNMR.
Heated at 140°C.
Heated for 20 min.
With these conditions, it appeared the nitro group is necessary for full conversion. Replacing the nitro with a nitrile group furnished 80% conversion after heating to 140°C for 20 min with no detection of the hydrolysis product (Table 2, entry 12). Capacity for derivatization off the nitrile group greatly increases the utility of the aniline product for larger synthetic efforts. The addition of trifluoromethyl groups worked in the presence of nitro groups (Table 2, entries 9 and 10), but no conversion was observed if –CF3 was the sole electron withdrawing group (Table 2, entries 13 and 14).
Fluorine was successfully replaced by chlorine in one of the more activated samples (Table 2, entry 15). To achieve complete conversion, an increase in temperature to 140°C and additional heating time was required. The less activated chlorine example showed only 20% conversion under similar conditions (Table 2, entry 16). Attempting to go any higher in temperature led to reaction pressures that would be difficult to implement on an industrial scale.
To further examine the scope of the reaction, the reaction was performed in the presence of bulky aryl and heterocycle substituents on the nitro-fluoro-benzene starting material (Table 3). Full conversion was observed with starting materials containing the bulky substituents in the meta and para positions relative to the fluorine group were tolerated, although over half required additional heating times, up to 20 min (entries 1, 5–7, 9, 11, 12, Table 3). Interestingly, we did not observe any conversion when the additions were made ortho to the fluorine, even with additional time and increased heating. We believe this is simply an issue of steric hindrance.
Table 3.
Synthesis of anilines from heterocycle substituted aryl halidesa.
| Entry | Subst. | Prod. | Conv.b (%) | Yield (%) | Entry | Subst. | Prod. | Conv.b (%) | Yield (%) |
|---|---|---|---|---|---|---|---|---|---|
| 1 |
|
|
100 | 99 | 7c |
|
|
100 | 99 |
| 2 |
|
|
100 | 99 | 8c |
|
|
100 | 99 |
| 3 |
|
|
100 | 99 | 9c |
|
|
100 | 99 |
| 4 |
|
|
100 | 99 | 10c, d |
|
|
0 | N/A |
| 5 |
|
|
100 | 99 | 11c, d |
|
|
0 | N/A |
| 6 |
|
|
100 | 99 | 12c, d |
|
|
0 | N/A |
Conditions: Unless otherwise stated, 50 mg starting material added 1 mL of 30% NH4OH. Heated in microwave at 130°C for 10 min.
Determined by 1HNMR.
Heated for 20 min.
Heated at 140°C.
To produce phenols, a similar procedure was developed using LiOH as the hydroxide source. Ten minutes of heating at 130°C showed incomplete conversion, and an additional 10 min of heating led to complete conversion. A small sample of compounds previously used were successfully converted into phenols (Table 4). Attempts of hydroxylation with weaker activating groups were still unsuccessful even when heating up to 160°C. This is likely a result of the decreased nucleophilicity of oxygen when compared with amine.
Table 4.
Synthesis of phenols from aryl halidesa.
Conditions: Unless otherwise stated, 100 mg starting material added 2 mL of 30% LiOH. Heated in microwave at 130°C for 20 min.
Determined by 1HNMR.
Heated at 140°C.
Heated for 20 min.
Finally, an efficient one-pot protocol was designed for amination and subsequent reduction to yield benzenediamines (Table 5). Following amination, reactions were heated to remove excess ammonia until the pH of the reaction mixture was neutral. A catalytic amount of 10% Pd/C was added and the reaction was sealed. Using a syringe and needle, hydrazine hydrate was added. Heating at 100°C for 20 min yielded complete conversion. Hydrazine hydrate is an effective, liquid hydrogen source that eliminates handling a flammable gas, allows for precise use of resources, and produces nitrogen gas as the sole byproduct. Six benzenediamine analogs were produced using the developed protocol.
Table 5.
Synthesis of benzenediamines from aryl halides.
| Entry | Substrate | Product | Conv.a (%) | Yield (%) |
|---|---|---|---|---|
| 1 |
|
|
100 | 99 |
| 2 |
|
|
100 | 99 |
| 3 |
|
|
100 | 76 |
| 4 |
|
|
100 | 99 |
| 5 |
|
|
100 | 89 |
Determined by 1HNMR.
Conclusions
In conclusion, we have presented a novel and green method to produce substituted anilines, phenols, and benzenediamines. This method is a further testament to the value of microwave assistance in reactions to develop greener synthetic routes. Because of its simplicity in work-up, brevity in the reaction setting, and eco-friendliness, this new method may serve as a standard for industrial scale synthesis of anilines and phenols. The methodology will also be especially important in the medicinal chemistry and drug discovery field where the efficient transformation to amines and phenols is of great use for the formation of larger pharmaceutically active compounds.
Experimental
General
All solvents, reagents, and catalysts were commercially purchased and used without further purification. For products purified using flash chromatography, silica gel (0.035–0.070 mm, 60 Å) was used as the stationary phase, eluting with hexane/ethyl acetate mixtures. All microwave reactions were completed in microwave vials and used a Biotage Initiatior microwave synthesizer. 1HNMR spectra and 13CNMR spectra were recorded at 400 and 100 MHz, respectively, using a Varian 400 MHz instrument (Model# 4001S41ASP) for all reaction products.
General procedure for the amination of aryl halides
100 mg (0.361–0.826 mmol) of starting material was added to 2 mL of 28–30% ammonium hydroxide solution in a microwave vial. The vial was sealed and heated in microwave at 130–140°C for 5–20 min, until thin layer chromatography (TLC) showed complete conversion. The product was extracted in a separatory funnel using dichloromethane or dichloromethane/isopropanol 4:1. The organic layer was dried using Na2SO4 and solvent removed under reduced pressure.
General procedure for the hydroxylation of aryl halides
100 mg (0.458–0.826 mmol) of starting material was added to 2 mL of 30% lithium hydroxide solution in a microwave vial. The vial was sealed and heated in microwave at 130–140°C for 5–20 min, until TLC showed complete conversion. The product was extracted in a separatory funnel using dichloromethane or dichloromethane/isopropanol 4:1. The organic layer was dried using Na2SO4 and solvent removed under reduced pressure.
General procedure for the synthesis of starting materials 17a-28a
A solution of the aryl halide (250 mg, 1.136 mmol), the boronic acid (1.136 mmol), Pd2(dba)3 (20.81 mg, 0.023 mmol), P(Cy)3 (19.12 mg, 0.068 mmol), and Na2CO3 (482 mg, 4.55 mmol) in argon flushed DMF/H2O 4:1 (5 mL) was heated at 85°C for 16 h. The reaction mixture was cooled to room temperature and diluted with ethyl acetate. The organic layer was washed with saturated NaHCO3 (3 × 15 mL) and deionized water (3×15 mL). The organic layer was dried over Na2SO4 and solvent removed under reduced pressure. The crude product was purified using flash chromatography (SiO2, hexane/ethyl acetate).
General procedure for the synthesis of benzenediamines
100 or 200 mg (0.584–0.956 mmol) of starting material was added to 2 mL of 28–30% ammonium hydroxide solution in a microwave vial. The vial was sealed and heated in microwave at 130–140°C for 5–20 min, until TLC showed complete conversion. Following, the reaction solution was refluxed with conventional heating unsealed for 20 min or until the reaction pH was neutral. A catalytic amount of 10% Pd/C was added and the reaction vessel was re-sealed. Hydrazine (10 EQ) was added and the reaction was heated with conventional heating to 100°C for 20 min, until TLC showed complete conversion. The reaction was filtered over celite to remove Pd/C and solvent removed under reduced pressure. The crude product was purified using flash chromatography (SiO2, hexane/ethyl acetate).
Physical and spectroscopic data of isolated products
2-nitroaniline (1b)
Orange solid, 93%. 1H NMR (400 MHz, Chloroform-d) δ 8.12 (dd, J = 8.6, 1.4 Hz, 1H), 7.40–7.31 (m, 1H), 6.81 (dd, J = 8.4, 1.1 Hz, 1H), 6.71 (ddd, J = 8.6, 7.0, 1.2 Hz, 1H), 6.4 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 144.76, 135.69, 132.12, 126.11, 118.80, 116.90.
4-nitroaniline (2b)
Yellow solid, 94% (15% when completed with 4-chloronitrobenzene). 1H NMR (400 MHz, Chloroform-d) δ 8.07 (d, J = 9.0 Hz, 2H), 6.63 (d, J = 9.0 Hz, 2H), 4.41 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 152.49, 126.34, 115.69, 113.36.
2-fluoro-4-nitroaniline (4b)
Yellow solid, 98%%. 1H NMR (400 MHz, Chloroform-d) δ 7.93 (m, 2H), 6.77 (m, 1H), 4.45 (s, 1H). 13C NMR (100 MHz, Chloroform-d) δ 149.04 (d, J = 242.8 Hz), 141.50, 141.38, 121.70 (d, J = 2.7 Hz), 114.26 (d, J = 4.2 Hz), 111.84 (d, J = 23.0 Hz).
2-chloro-4-nitroaniline (5b)
Yellow solid, 99%. 1H NMR (400 MHz, Chloroform-d) δ 8.21 (d, J = 2.5 Hz, 1H), 8.00 (dd, J = 9.0, 2.5 Hz, 1H), 6.76 (d, J = 9.0 Hz, 1H), 4.82 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 148.82, 125.96, 124.33, 117.70, 113.68.
2-bromo-4-nitroaniline (6b)
Yellow solid, 86%. 1H NMR (400 MHz, Chloroform-d) δ 8.37 (d, J = 2.5 Hz, 1H), 8.03 (dd, J = 9.0, 2.5 Hz, 1H), 6.75 (d, J = 9.0 Hz, 1H), 4.86 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 149.93, 138.90, 129.17, 124.89, 113.46, 106.94.
5-bromo-2-nitroaniline (7b)
Orange solid, 97%. 1H NMR (400 MHz, Chloroform-d) δ 7.98 (d, J = 9.1 Hz, 1H), 7.01 (d, J = 2.0 Hz, 1H), 6.82 (dd, J = 9.1, 2.0 Hz, 1H), 6.10 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 145.08, 130.61, 127.55, 120.92, 120.38, 120.10.
4-bromo-2-nitroaniline (8b)
Orange solid, 96%δ. 1H NMR (400 MHz, Chloroform-d) δ 8.28 (d, J = 2.3 Hz, 1H), 7.43 (dd, J = 8.9, 2.3 Hz, 1H), 6.73 (d, J = 8.9 Hz, 1H), 6.08 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 143.59, 138.46, 132.42, 128.25, 120.34, 107.80.
4-nitro-2-(trifluoromethyl)aniline (9b)
Yellow solid, 84%%. 1H NMR (400 MHz, Chloroform-d) δ 8.40 (d, J = 2.5 Hz, 1H), 8.19 (dd, J = 9.0, 2.5 Hz, 1H), 6.77 (d, J = 9.0 Hz, 1H), 4.92 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 149.86, 137.86, 128.66, 124.13 (q, J = 5.5 Hz), 123.59 (q, J = 272.5 Hz) 116.39, 112.26 (q, J = 31.9 Hz).
2-nitro-4-(trifluoromethyl)aniline (10b)
Yellow solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.43 (d, J = 2.1 Hz, 1H), 7.56 (dd, J = 8.8, 2.1 Hz, 1H), 6.92 (d, J = 8.8 Hz, 1H), 6.38 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 146.46, 137.08, 131.64 (q, J = 3.2 Hz), 124.39 (q, J = 4.4 Hz) 123.40 (q, J = 270.9 Hz), 119.43.
2,4-dinitroaniline (11b)
Pale Yellow solid, 96%%. 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 2.7 Hz, 1H), 8.39 (s, 2H), 8.17 (dd, J = 9.4, 2.7 Hz, 1H), 7.12 (d, J = 9.4 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ 150.24, 135.52, 129.72, 129.08, 123.81, 120.20.
4-amino-2-bromobenzonitrile (12b)
White solid, 78%. 1H NMR (400 MHz, Chloroform-d) δ 7.38 (d, J = 8.5 Hz, 1H), 6.89 (d, J = 2.3 Hz, 1H), 6.58 (dd, J = 8.5, 2.3 Hz, 1H), 4.24 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 151.80, 135.84, 132.25, 132.16, 127.03, 118.43, 113.77.
2-nitro-4-(trifluoromethyl)aniline (15b)
Yellow solid, 90%%. 1H NMR (400 MHz, Chloroform-d) δ 8.43 (s, 1H), 7.56 (dd, J = 8.8, 2.0 Hz, 1H), 6.90 (d, J = 8.8 Hz, 1H), 6.35 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 146.46, 137.08, 131.64 (q, J = 3.2 Hz), 124.39 (q, J = 4.4 Hz) 123.40 (q, J = 270.9 Hz), 119.43.
2-methyl-4-nitroaniline (17b)
Yellow solid, 99%. 1H NMR (400 MHz, CDCl3) δ 8.02–7.97 (m, 2H), 6.65 (d, J = 8.7 Hz, 1H), 4.34 (s, 2H), 2.24 (s, 3H).
2-methoxy-4-nitroaniline (18b)
Yellow solid, 84%. 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 8.7, 2.4 Hz, 1H), 7.69 (d, J = 2.4 Hz, 1H), 6.66 (d, J = 8.7 Hz, 1H), 4.54 (s, 2H), 3.97 (s, 3H).
3-(4-fluoro-3-nitrophenyl)thiophene (19a)
Brown/orange solid, 62.1%, 157.5 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.26 (dd, J = 7.0, 2.3 Hz, 1H), 7.85–7.81 (m, 1H), 7.55–7.50 (m, 1H), 7.48-7.45 (m, 1H), 7.38–7.36 (m, 1H), 7.33 (dd, J = 10.5, 8.7 Hz, 1H). 13C NMR (100 MHz, Chloroform-d) δ 154.44 (d, J = 264.9 Hz), 138.74, 133.04 (d, J = 8.3 Hz), 128.96, 128.38, 127.41, 125.79, 123.47 (d, J = 2.9 Hz), 121.98 (d, J = 1.0 Hz), 118.81 (d, J = 21.1 Hz).
2-nitro-4-(thiophen-3-yl)aniline (19b)
Red solid, 99%. 1H NMR (400 MHz, DMSO-d6) δ 8.23 (d, J = 2.2 Hz, 1H), 7.84–7.78 (m, 2H), 7.64–7.60 (m, 1H), 7.54–7.49 (m, 3H), 7.08 (d, J = 8.8 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ 145.70, 140.11, 134.52, 130.61, 127.64, 126.09, 123.54, 121.99, 120.30, 120.11.
2-(4-fluoro-3-nitrophenyl)thiophene (20a)
Brown solid, 50.4%, 127.9 mg.1H NMR (400 MHz, Chloroform-d) δ 8.26 (dd, J = 6.9, 2.4 Hz, 1H), 7.85-7.81 (m, 1H), 7.39–7.28 (m, 3H), 7.13 (dd, J = 5.1, 3.7 Hz, 1H). 13C NMR (100 MHz, Chloroform-d) δ 154.49 (d, J = 265.5 Hz), 140.32, 132.43 (d, J = 8.3 Hz), 131.73 (d, J = 4.4 Hz), 128.50, 126.54, 124.78, 122.81, 118.97 (d, J = 21.4 Hz).
2-nitro-4-(thiophen-2-yl)aniline (20b)
Red solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.36 (d, J = 2.2 Hz, 1H), 7.62 (dd, J = 8.7, 2.2 Hz, 1H), 7.26–7.23 (m, 2H), 7.07 (dd, J = 5.1, 3.7 Hz, 1H), 6.84 (d, J = 8.7 Hz, 1H), 6.13 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 143.71, 142.26, 133.58, 128.08, 124.41, 124.15, 122.69, 122.64, 119.31.
4’-fluoro-2,5-dimethoxy-3’-nitro-1,1‘-biphenyl (21a)
Yellow solid, 40.3%, 127.0 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.22 (dd, J = 7.2, 2.3 Hz, 1H), 7.80-7.76 (m, 1H), 7.29 (dd, J = 10.7, 8.7 Hz, 1H), 6.96–6.83 (m, 3H). 13C NMR (100 MHz, Chloroform-d) δ 154.49 (d, J = 264.7 Hz), 153.85, 150.45, 136.50 (d, J = 8.4 Hz), 135.30 (d, J = 4.4 Hz), 127.72, 126.84 (d, J = 2.8 Hz), 117.81 (d, J = 20.8 Hz), 116.40, 114.28, 112.60, 56.13, 55.83.
2’,5’-dimethoxy-3-nitro-[1,1‘-biphenyl]-4-amine (21b)
Orange solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.31 (d, J = 1.8 Hz, 1H), 7.61 (dd, J = 8.6, 1.8 Hz, 1H), 6.92-6.82 (m, 4H), 6.10 (s, 2H), 3.81 (s, 3H), 3.77 (s, 3H). 13C NMR (100 MHz, Chloroform-d) δ 153.84, 150.71, 143.69, 137.22, 132.01, 129.17, 127.44, 126.32, 118.27, 116.09, 113.23, 112.57, 56.23, 55.82.
4,4’-difluoro-3-nitro-1,1’-biphenyl (22a)
Yellow solid, 69.7%, 186.4 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.18 (dd, J = 7.0, 2.4 Hz, 1H), 7.81–7.78 (m, 1H), 7.57–7.49 (m, 2H), 7.36 (dd, J = 10.5, 8.7 Hz, 1H), 7.20–7.12 (m, 2H). 13C NMR (100 MHz, Chloroform-d) δ 163.06 (d, J = 248.9 Hz), 154.81 (d, J = 265.4 Hz), 137.32 (d, J = 4.3 Hz), 133.84 (d, J = 3.3 Hz), 133.68 (d, J = 8.4 Hz), 128.74 (d, J = 8.2 Hz), 124.19 (d, J = 2.7 Hz), 118.88 (d, J = 21.1 Hz), 116.22 (d, J = 21.8 Hz).
4’-fluoro-3-nitro-[1,1‘-biphenyl]-4-amine (22b)
Orange solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.32 (d, J = 2.1 Hz, 1H), 7.59 (dd, J = 8.6, 2.1 Hz, 1H), 7.53–7.47 (m, 2H), 7.16–7.08 (m, 2H), 6.89 (d, J = 8.6 Hz, 1H), 6.10 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 162.36 (d, J = 246.8 Hz), 143.70, 134.94, 134.31, 129.40, 127.91 (d, J = 8.1 Hz), 123.76, 119.36, 115.83 (d, J = 21.5 Hz).
4-fluoro-4’-methoxy-3-nitro-1,1‘-biphenyl (23a)
Orange solid, 72.5%, 203.8 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.21 (dd, J = 7.0, 2.4 Hz, 1H), 7.80–7.76 (m, 1H), 7.53–7.48 (m, 2H), 7.33 (dd, J = 10.5, 8.7 Hz, 1H), 7.03–6.98 (m, 2H), 3.87 (s, 3H). 13C NMR (100 MHz, Chloroform-d) δ 160.03, 154.40 (d, J = 264.3 Hz), 143.28, 133.29 (d, J = 8.3 Hz), 128.95, 128.38, 128.08, 123.66 (d, J = 2.9 Hz), 118.66 (d, J = 21.0 Hz), 114.61, 55.40.
4’-methoxy-3-nitro-[1,1‘-biphenyl]-4-amine (23b)
Red solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.31 (d, J = 2.2 Hz, 1H), 7.59 (dd, J = 8.6, 2.2 Hz, 1H), 7.47 (d, J = 8.7 Hz, 2H), 6.96 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.6 Hz, 1H), 6.07 (s, 2H), 3.84 (s, 3H). 13C NMR (100 MHz, Chloroform-d) δ 134.25, 128.95, 128.38, 128.10, 127.38, 123.20, 119.24, 114.62, 114.36, 55.37.
1-(4-fluoro-3-nitrophenyl)naphthalene (24a)
Pale yellow solid, 62.6%, 190.0 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.11 (dd, J = 7.1, 1.9 Hz, 1H), 7.90–7.84 (m, 2H), 7.70 (d, J = 8.4 Hz, 1H), 7.68–7.63 (m, 1H), 7.52–7.41 (m, 3H), 7.36–7.30 (m, 2H). 13C NMR (100 MHz, Chloroform-d) δ 154.81 (d, J = 265.1 Hz), 137.75 (d, J = 4.4 Hz), 136.93 (d, J = 8.4 Hz), 136.39, 133.80, 131.05, 128.99, 128.64, 127.32, 127.21 (d, J = 2.7 Hz), 126.88, 126.28, 125.33, 124.81, 118.44, 118.24.
4-(naphthalen-1-yl)-2-nitroaniline (24b)
Orange solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.28 (s, 1H), 7.91 (d, J = 7.8 Hz, 1H), 7.86 (dd, J = 8.3, 4.2 Hz, 2H), 7.56–7.38 (m, 5H), 6.93 (d, J = 8.5 Hz, 1H), 6.16 (s, 2H). 13C NMR (100 MHz, Chloroform-d) δ 143.83, 137.78, 137.59, 133.87, 131.46, 129.74, 128.49, 128.04, 126.99, 126.93, 126.35, 125.95, 125.42, 125.36, 124.80, 118.67.
3,4’-difluoro-4-nitro-1,1’-biphenyl (25a)
Brown/orange solid. 62.1%, 166 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.16 (t, J = 8.1 Hz, 1H), 7.61–7.56 (m, 2H), 7.47 (s, 1H), 7.46–7.43 (m, 1H), 7.23–7.17 (m, 2H). 13C NMR (101 MHz, Chloroform-d) δ 163.63 (d, J = 250.4 Hz), 155.88 (d,J = 265.0 Hz), 148.12, 133.69, 129.10 (d, J = 8.5 Hz), 127.56, 126.75 (d, J = 2.4 Hz), 122.69 (d, J = 3.6 Hz), 116.44 (d, J = 21.7 Hz), 116.37 (d, J = 21.8 Hz).
4’-fluoro-4-nitro-[1,1‘-biphenyl]-3-amine (25b)
Yellow solid, 99%.’ 1H NMR (400 MHz, Chloroform-d) δ 8.18 (d, J = 8.9 Hz, 1H), 7.57–7.52 (m, 2H), 7.18–7.12 (m, 2H), 6.93 (d, J = 1.9 Hz, 1H), 6.88 (dd, J = 8.9, 1.9 Hz, 1H), 6.15 (s, 2H). 13C NMR (100 MHz, DMSO-d6) δ 163.04 (d, J = 246.4 Hz), 146.82, 146.29, 135.19 (d, J = 3.1 Hz), 129.94, 129.40 (d, J = 8.4 Hz), 126.70, 116.82, 116.40 (d, J = 21.6 Hz), 114.81.
1-(3-fluoro-4-nitrophenyl)naphthalene (26a)
Brown/orange solid, 74.4%, 226.0 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.20 (t, J = 8.1 Hz, 1H), 7.95 (d, J = 8.4 Hz, 2H), 7.79 (d, J = 8.2 Hz, 1H), 7.59–7.48 (m, 3H), 7.47–7.40 (m, 3H). 13C NMR (100 MHz, Chloroform-d) δ 155.39 (d, J = 265.5 Hz), 149.21 (d, J = 8.5 Hz), 136.51 (d, J = 1.4 Hz), 133.78, 130.59, 129.46, 128.69, 127.07 (d, J = 9.4 Hz), 126.40, 126.19 (d, J = 3.8 Hz), 126.09 (d, J = 2.4 Hz), 125.29, 124.79, 119.90, 119.69.
5-(naphthalen-1-yl)-2-nitroaniline (26b)
Brown/yellow solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.23 (d, J = 8.8 Hz, 1H), 7.93–7.85 (m, 3H), 7.54–7.44 (m, 3H), 7.41 (d, J = 6.9 Hz, 1H), 6.92 (d, J = 1.7 Hz, 1H), 6.85 (dd, J = 8.8, 1.3 Hz, 1H), 6.15 (s, 2H). 13C NMR (100 MHz, DMSO-d6) δ 147.85, 146.58, 138.21, 133.77, 130.62, 129.99, 128.99, 128.91, 127.13, 126.86, 126.62, 126.02, 125.93, 125.41, 120.23, 117.99.
3-fluoro-4’-methoxy-4-nitro-1,1‘-biphenyl (27a)
Pale orange solid, 82%, 231 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.16–8.10 (m, 1H), 7.59–7.54 (m, 2H), 7.48–7.41 (m, 2H), 7.04–6.99 (m, 2H), 3.88 (s, 3H). 13C NMR (100 MHz, Chloroform-d) δ 160.89, 156.1 (d, J = 264.3 Hz), 148.82 (d, J = 8.7 Hz), 129.69 (d, J = 1.8 Hz), 128.95, 128.48, 126.66 (d, J = 2.4 Hz), 122.07 (d, J = 3.5 Hz), 115.64 (d, J = 21.7 Hz), 114.71, 55.44.
4’-methoxy-4-nitro-[1,1’-biphenyl]-3-amine (27b)
Orange solid, 99%%. 1H NMR (400 MHz, Chloroform-d) δ 8.16 (d, J = 8.9 Hz, 1H), 7.53 (d, J = 8.8 Hz, 2H), 6.99 (d, J = Hz, 2H), 6.93 (d, J = 1.8 Hz, 1H), 6.91 (dd, J = 8.9, 1.8 Hz, 1H), 6.12 (s, 2H), 3.86 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 160.38, 148.08, 144.92, 131.15, 128.50, 128.35, 126.82, 116.00, 115.60, 114.39, 55.39.
2-(2-fluoro-5-nitrophenyl)thiophene (28a)
Yellow/green solid, 22%, 55.3 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.22 (d, J = 2.8 Hz, 1H), 8.08 (dd, J = 9.1, 2.8 Hz, 1H), 7.36 (dd, J = 5.1, 1.0 Hz, 1H), 7.28 (dd, J = 3.6, 1.0 Hz, 1H), 7.07 (dd, J = 5.1, 3.6 Hz, 1H), 6.98 (d, J = 9.1 Hz, 1H). 13C NMR (100 MHz, Chloroform-d) δ 156.61, 141.66 (d, J = 208.4 Hz), 140.92, 128.50, 128.38 (d, J = 18.9 Hz), 128.31 (d, J = 12.9 Hz), 127.46, 126.92, 126.25 (d, J = 0.7 Hz), 124.07.
2,4’-difluoro-5-nitro-1,1’-biphenyl (29a)
Yellow solid, 54%, 144 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.09 (dd, J = 9.1, 2.7 Hz, 1H), 8.01 (d, J = 2.7 Hz, 1H), 7.49–7.41 (m, 2H), 7.16–7.08 (m, 2H), 6.92 (d, J = 9.1 Hz, 1H). 13C NMR (100 MHz, Chloroform-d) δ 162.06 (d, J = 247.2 Hz), 156.08, 142.68, 136.47 (d, J = 3.5 Hz), 129.84 (d, J = 7.9 Hz), 128.43 (d, J = 11.7 Hz), 128.08, 124.21, 115.88 (d, J = 1.7 Hz), 115.66.
1-(2-fluoro-5-nitrophenyl)naphthalene (30a)
Yellow solid, 51%, 153.3 mg. 1H NMR (400 MHz, Chloroform-d) δ 8.18 (dd, J = 9.2, 2.8 Hz, 1H), 8.09 (d, J = 2.8 Hz, 1H), 7.91–7.84 (m, 2H), 7.59 (d, J = 8.3 Hz, 1H), 7.54–7.38 (m, 4H), 6.92 (d, J = 9.2 Hz, 1H). 13C NMR (101 MHz, Chloroform-d) δ 156.00, 138.71, 138.40, 133.68, 131.13, 130.53, 129.57, 128.98, 128.40, 128.33 (d, J = 28.4 Hz), 127.12, 126.63 (d, J = 244.0 Hz) 126.45, 126.09, 125.56 (d, J = 6.1 Hz), 124.63.
4-nitrophenol (31b)
White solid, 84%%. 1H NMR (400 MHz, Chloroform-d) δ 8.19 (d, J = 9.1 Hz, 2H), 6.93 (d, J = 9.1 Hz, 2H), 5.84 (s, 1H). 13C NMR (100 MHz, Chloroform-d) δ 161.65, 141.43, 126.31, 115.73.
4-bromo-2-nitrophenol (32b)
Brown solid, 86%. 1H NMR (400 MHz, Chloroform-d) δ 10.49 (s, 1H), 8.26 (d, J = 2.4 Hz, 1H), 7.67 (dd, J = 8.9, 2.4 Hz, 1H), 7.08 (d, J = 8.9 Hz, 1H). 13C NMR (100 MHz, Chloroform-d) δ 154.10, 140.33, 127.31, 121.72, 111.69.
4-nitro-2-(trifluoromethyl)phenol (33b)
White solid, 70δ. 1H NMR (400 MHz, DMSO-d6) δ 9.50 (b, 1H), 8.57 (s, 1H), 8.35–8.31 (m, 18H), 7.14 (d, J = 9.2 Hz, 11H). 13C NMR (100 MHz, DMSO-d6) δ 170.28, 166.60, 139.43, 130.45, 126.94, 118.93, 114.63.
2-nitro-4-(trifluoromethyl)phenol (35b)
Brown solid, 35%%. 1H NMR (400 MHz, DMSO-d6) δ 12.55 (b, 1H), 8.34 (d, J = 2.1 Hz, 1H), 8.02 (dd, J = 8.7, 2.1 Hz, 1H), 7.18 (d, J = 8.7 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ 166.09, 156.39, 137.14, 135.81, 127.30, 121.72, 119.84.
benzene-1,4-diamine (36b)
Dark solid, 99%%. 1H NMR (400 MHz, CDCl3) δ 6.60 (s, 1H), 3.22 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 138.60, 116.74.
benzene-1,2-diamine (37b)
Dark solid, 99%%. 1H NMR (400 MHz, CDCl3) δ 6.78–6.71 (m, 4H), 3.33 (s, 4H).
2-fluorobenzene-1,4-diamine (38b)
Dark solid, 76%%. 1H NMR (400 MHz, CDCl3) δ 6.68–6.63 (m, 1H), 6.47–6.43 (m, 1H), 6.37–6.35 (m, 1H), 3.38 (s, 4H). 13C NMR (100 MHz, CDCl3) δ 126.02 (d, J = 13.3 Hz), 118.49 (d, J = 4.6 Hz), 116.74, 111.49 (d, J = 3.2 Hz), 103.59 (d, J = 22.2 Hz).
2-(trifluoromethyl)benzene-1,4-diamine (39b)
Dark solid, 99%%. 1H NMR (400 MHz, CDCl3) δ 6.84 (d, J = 2.6 Hz, 1H), 6.78–6.69 (m, 1H), 6.65 (d, J = 8.5 Hz, 1H), 3.65 (s, 4H).
2-methoxybenzene-1,4-diamine (40b)
Dark solid, 89%%. 1H NMR (400 MHz, CDCl3) δ 6.59 (d, J = 8.1 Hz, 1H), 6.29 (d, J = 2.4 Hz, 1H), 6.22 (dd, J = 8.1, 2.4 Hz, 1H), 3.83 (s, 3H), 3.21 (s, 4H). 13C NMR (100 MHz, CDCl3) δ 148.50, 139.01, 128.20, 116.37, 107.68, 100.12, 55.42.
Acknowledgments
Funding
This work was supported by the National Cancer Institute and National Institutes of Health [grant number 5F99CA212480-02] and University of Arkansas Startup Funding. This work was also supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [grant number P20 GM109005]. H. L. was supported by the grant numbers NIH 1R01CA194094-010 and 1R01CA197178-01A1.
Footnotes
Disclosure statement
No potential conflict of interest was reported by the author(s).
References
- [1].Quick AJ J. Am. Chem. Soc 1920, 42 (5), 1033–1042. [Google Scholar]
- [2].Fyfe CA Nucleophilic Attack by Hydroxide and Alkoxide Ions In The Hydroxyl Group (1971);Patai, Saul, Ed.;John Wiley & Sons, Ltd: Hoboken, New Jersey, 2010; pp 51–131. [Google Scholar]
- [3].Surry DS; Buchwald SL J. Am. Chem. Soc 2007, 129 (34),10354–10355. [DOI] [PubMed] [Google Scholar]
- [4].Shen Q; Hartwig JF J Am Chem Soc 2006, 128 (31), 10028–10029. [DOI] [PubMed] [Google Scholar]
- [5].Vo GD; Hartwig JF J. Am. Chem. Soc 2009, 131 (31), 11049–11061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Cheung CW; Buchwald SL J. Org. Chem 2014, 79 (11), 5351–5358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Schulz T; Torborg C; Schäffner B; Huang J; Zapf A;Kadyrov R; Börner A; Beller M Angew. Chem. Int. Ed 2009, 48 (5), 918–921. [DOI] [PubMed] [Google Scholar]
- [8].Anderson KW; Ikawa T; Tundel RE; Buchwald SL J. Am. Chem. Soc 2006, 128 (33), 10694–10695. [DOI] [PubMed] [Google Scholar]
- [9].Chen G; Chan ASC; Kwong FY Tetrahedron Lett 2007, 48 (3), 473–476. [Google Scholar]
- [10].Willis MC Angew. Chem. Int. Ed 2007, 46 (19), 3402–3404. [DOI] [PubMed] [Google Scholar]
- [11].Xu H-J; Liang Y-F; Cai Z-Y; Qi H-X; Yang C-Y; Feng Y-S J. Org. Chem 2011, 76 (7), 2296–2300. [DOI] [PubMed] [Google Scholar]
- [12].Xia N; Taillefer M Angew. Chem. Int. Ed 2009, 48 (2), 337–339. [DOI] [PubMed] [Google Scholar]
- [13].Wang D; Cai Q; Ding K Adv. Synth. Catal 2009, 351 (11–12), 1722–1726. [Google Scholar]
- [14].Rao H; Fu H; Jiang Y; Zhao Y Angew. Chem. Int. Ed 2009, 121 (6), 1134–1136. [Google Scholar]
- [15].Xiao Y; Xu Y; Cheon H-S; Chae J J. Org. Chem 2013, 78(11), 5804–5809. [DOI] [PubMed] [Google Scholar]
- [16].Kormos CM; Leadbeater NE Tetrahedron 2006, 62 (19), 4728–4732. [Google Scholar]
- [17].Yang K; Li Z; Wang Z; Yao Z; Jiang S Org. Lett 2011, 13(16), 4340–4343. [DOI] [PubMed] [Google Scholar]
- [18].Chan C-C; Chen Y-W; Su C-S; Lin H-P; Lee C-F Eur. J. Org. Chem 2011, 2011 (36), 7288–7293. [Google Scholar]
- [19].Ke F; Chen X; Li Z; Xiang H; Zhou X RSC Adv 2013, 3 (45), 22837–22840. [Google Scholar]
- [20].Tasneem AMM; Rajanna KC; Saiparakash PK Synth. Commun 2001, 31 (7), 1123–1127. [Google Scholar]
- [21].Ren Y; Cheng L; Tian X; Zhao S; Wang J; Hou C Tetrahedron Lett 2010, 51 (1), 43–45. [Google Scholar]
- [22].Thakur KG; Sekar G Chem. Commun 2011, 47 (23), 6692–6694. [DOI] [PubMed] [Google Scholar]
- [23].Thakur KG; Ganapathy D; Sekar G Chem. Commun 2011, 47 (17), 5076–5078. [DOI] [PubMed] [Google Scholar]
- [24].Ji P; Atherton JH; Page MI J. Org. Chem 2012, 77 (17), 7471–7478. [DOI] [PubMed] [Google Scholar]
- [25].Wang D; Kuang D; Zhang F; Tang S; Jiang W Eur. J. Org. Chem 2014, 2014 (2), 315–318. [Google Scholar]
- [26].Wu Z; Jiang Z; Wu D; Xiang H; Zhou X Eur. J. Org. Chem 2010, 2010 (10), 1854–1857. [Google Scholar]
- [27].Yang D; Fu H Chem. Eur. J 2010, 16 (8), 2366–2370. [DOI] [PubMed] [Google Scholar]
- [28].Lidström P; Tierney J; Wathey B; Westman J Tetrahedron 2001, 57 (45), 9225–9283. [Google Scholar]
- [29].Yu C-W; Chen GS; Huang C-W; Chern J-W Org. Lett 2012, 14 (14), 3688–3691 [DOI] [PubMed] [Google Scholar]
